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Abstract: Medicinal plants, especially rich in polyphenolic compounds, have been suggested to be chemopreventive
on account of antioxidative properties. Salvia officinalis L., an aromatic and medicinal plant, is widely used in folk
medicine and is well known for its antioxidant properties. Therefore, the present study was designed to investigate the
antioxidative, possible genotoxic, and antigenotoxic potency of S. officinalis extract against cyclophosphamide (CYP)induced oxidative stress and genotoxicity in Wistar albino rats. Animals were orally dosed with S. officinalis extract
(50, 100, and 150 mg/kg body weight) for 7 days before the administration of a single intraperitoneal dose of CYP (40
mg/kg body weight). The biochemical and cytogenetic determinations were carried out 24 h after CYP injection. The
activities of malondialdehyde, superoxide dismutase, and catalase were determined in liver, kidney, and heart tissues.
The frequency of micronucleated polychromatic erythrocytes (MNPCEs) and the ratio of polychromatic erythrocytes
to normochromatic erythrocytes (PCE/NCE) were also evaluated. Additionally, the antioxidant capacity of the extract
was analyzed. The micronucleus assay revealed that all doses of the extract tested presented no genotoxic activity; in
addition, the 2 highest doses reduced the MNPCEs and increased the PCE/NCE ratio in the bone marrow and restored
the oxidative stress markers in CYP-treated rats. In correlation with these findings, S. officinalis extract exhibited high
antioxidant capacity. The results of the present study suggest that the methanolic extract of S. officinalis has a protective
effect against CYP-induced oxidative stress and genotoxicity through its antioxidant property.
Key words: Cyclophosphamide, Salvia officinalis, micronucleus, oxidative stress, antioxidant capacity

Introduction
Cyclophosphamide (CYP) is a cytotoxic alkylating
agent that has been used extensively in veterinary
medicine as an antineoplastic agent for the treatment
of several tumors such as sarcomas and carcinomas of
the lung and mammary gland (1). However, this drug
* E-mail: fustun@istanbul.edu.tr

646

has serious side effects such as inducing genotoxic
effects and renal (2) and hepatic damage (3), thereby
limiting its therapeutic use. Its cytotoxic effects result
from the reactive metabolites that alkylate DNA and
form a variety of DNA adducts that sufficiently alter
DNA structure or function (4), leading to formation
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of chromosome aberrations and micronuclei (5,6).
This antitumoral is also able to generate active oxygen
species such as superoxide anions and hydroxy
radicals that induce oxidative stress and inhibit the
activity of antioxidant enzymes in several tissues.
The use of antioxidants mitigates the side effects
associated with CYP treatment and more efficient
and comfortable therapy can be achieved (7–10).
In recent years, considerable attention has been
devoted to medicinal plants particularly rich in
polyphenols, mainly flavonoids and phenolic acids,
which exhibit antioxidant properties due to their
hydrogen-donating and metal-chelating capacities as
potential chemopreventive agents (11). The phenolic
compounds have demonstrated protective effects
against deleterious effects of genotoxic carcinogens
by scavenging reactive oxygen species (ROS) and
enhancing host antioxidant defense systems (12,13).
It is known that many plant infusions have a large
number of these molecules (14) and, hence, it is
reasonable to investigate whether plants have the
capacity to prevent the genotoxic potency of specific
mutagens or carcinogens that are known to generate
free radicals in nontumor cells both in vivo and in
vitro.
Salvia officinalis L., one of the widest-spread
members of the family Lamiaceae, has been used as a
traditional herbal medicine against a variety of diseases
in Turkey (15). The plant is reported to have multiple
pharmacological effects, including antibacterial
(16,17), antiviral (18), antiinflammatory (19),
hypoglycemic (20), fungistatic (21), antimutagenic
(22), anticancer (23), and antioxidative (24) effects.
The leaves of S. officinalis possess some therapeutic
effects due to the presence of mainly flavonoids;
phenolic compounds such as carnosic, rosmarinic,
caffeic, and salvianolic acids; and other phenolic
structure-based compounds (25–27) especially
found in alcohol-soluble fraction (28).
Several experimental studies have demonstrated
the antioxidant properties of S. officinalis extract and
some of its constituents (9,29,30), but no detailed
study has been carried out on the chemoprotective
effect of S. officinalis leaf extract against genotoxins.
Therefore, the present study was undertaken
to evaluate the antimutagenic and antioxidant
potential of the methanolic extract of S. officinalis

on CYP-induced genotoxicity and oxidative stress
in rats and to investigate the possible mechanism(s)
underlying these effects. Genotoxicity was induced
by administrating a single CYP dose in the presence
or absence of S. officinalis extract. Herbal protection
was assessed by monitoring micronucleus frequency
in bone marrow and endogenous antioxidants
superoxide dismutase (SOD) and catalase (CAT) and
lipid peroxidation in liver, kidney, and heart tissues,
as well as by determining the in vitro antioxidant
capacity of the plant extract.
Materials and methods
Cyclophosphamide monohydrate with a technical
purity of 97% was obtained from Acros Organics
(Belgium). All chemicals were of analytical reagent
grade, and the chemicals required for all biochemical
assays were obtained from Merck (Darmstadt,
Germany) and Sigma-Aldrich Chemical Co. (St.
Louis, Missouri, USA).
All of the experiments were carried out with male
Wistar rats, aged 8–10 weeks, weighing 220–280 g.
The male rats were chosen according to previous
studies that found that the clastogenic effects of CYP
were more pronounced in males than females (31).
The animals were housed in polypropylene cages at
room temperature (22-24 °C) with a 12-h light/dark
cycle and were acclimatized for 2 weeks prior to the
experimental use. Food and water were provided ad
libitum. The experimental protocol was approved
by İstanbul University’s Veterinary Faculty Ethic
Committee.
The aerial parts (leaves and flowers) of Salvia
officinalis L. were collected from the Gülpınar village
of Kumbağlar district, Ayancık, Çanakkale, Turkey,
during its flowering season between the months
of May and July in 2008. The voucher specimen of
this plant was deposited at the herbarium of the
Department of Biology, Cumhuriyet University,
Sivas, Turkey (CUFH), with voucher number AA
4332.
The plant was dried under shade at 25 °C and
ground in a blender. A 2-g dry plant sample was
soaked in 80% methanol overnight and homogenized
in an Ultra-Turrax apparatus by gradually increasing
the number of cycles per unit time. The obtained
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extract was transferred to centrifuge tubes,
centrifuged for 10 min (5000 rpm), and subsequently
filtered through a filter paper into a 100-mL flask.
The same procedure was repeated 3 times with 25mL portions of 80% methanol for the remaining part
of the plant. All filtered extracts were combined and
evaporated to dryness using a rotary evaporator;
the residue was dried under vacuum (yield: 20.1%)
and stored at 4 °C until use (32). The methanolic
extraction method was chosen according to studies
that reported the alcoholic extraction as the best
method for the extraction of polyphenol compounds,
and it was found that the alcoholic extract includes
a higher content of phenolic compounds than the
water extract (28,30).
The animals were divided into 8 groups of 6
animals each. Animals in group 1 received only the
standard diet and served as the control. Animals in
groups 2, 3, and 4 received 50 mg/kg, 100 mg/kg,
and 150 mg/kg body weight (bw) S. officinalis extract
alone by gavage for 7 days, respectively. Group 5 was
treated with a single dose of CYP (40 mg/kg bw) by
intraperitoneal route. Groups 6, 7, and 8 received
methanolic S. officinalis extract at concentrations of
50 mg/kg, 100 mg/kg, and 150 mg/kg bw by gavage
for 7 days, respectively, followed by CYP 1.5 h after
the final feeding. The doses of S. officinalis extracts
were based on the common dosage for humans, such
that the intake of leaf at a dose of 4–6 g/day and of
alcoholic extract at 2.5–7.5 g/day for a 70-kg person is
recommended (33). The animals were sacrificed 24 h
after CYP treatment. Both femurs were removed and
used for analysis of micronucleated polychromatic
erythrocytes (MNPCEs). The liver, kidney, and heart
tissues were surgically removed and kept at –80 °C
until the biochemical analyses.
Bone marrow cells for MNPCE assessment
were isolated and slides were prepared as described
previously (31,34) with slight modifications. Briefly,
rats were killed and the femurs were excised and
trimmed immediately. Bone marrow cells of both
femurs were flushed from the channel into a
centrifuge tube containing fetal calf serum. The cell
suspension was centrifuged at 2200 rpm for 10 min
and the supernatant was discarded. The pellet was
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resuspended in a drop of serum and smears were
prepared on glass slides. Four slides were prepared for
each rat. The air-dried slides were fixed in methanol
and stained with May-Grünwald and Giemsa. A
total of 2000 polychromatic erythrocytes (PCEs)
were screened per animal for scoring the frequency
of PCEs containing micronuclei and the ratio of
PCEs to normochromatic erythrocytes (NCEs). The
criteria for scoring and identification of micronuclei
were similar to those of earlier studies (35).
The effects of treatments on lipid peroxidation
and antioxidant enzymes were determined by
corresponding assays in every group. Tissue samples
were weighed and homogenized in appropriate
buffer (1.15% KCl) using a Teflon homogenizer
(Miccra D-1, ART Prozess & Labortechnik GmbH,
Germany). The homogenate was centrifuged at 4000
rpm for 5 min at 4 °C. Products of lipid peroxidation
were estimated by measuring the concentration of
malondialdehyde (MDA) expressed as thiobarbituric
acid-reactive substances according to the method
of Yoshoiko (36). Total SOD activity was analyzed
according to the method of Sun et al. (37) with a
slight modification by Durak et al. (38) based on the
inhibition of nitroblue tetrazolium reduction by the
xanthine/xanthine oxidase system as a superoxide
generator. CAT activity was determined by measuring
the decomposition of hydrogen peroxide according
to the method of Aebi (39) and was expressed
as k/g protein, where k is the first-order rate
constant. Contents of protein were measured in the
homogenates according to the method of Lowry et
al. (40) using bovine serum albumin as the standard.
The Trolox equivalent antioxidant capacity
(TEAC) values of plant extract and tissue
homogenates were determined by the cupric ion
reducing antioxidant capacity (CUPRAC) method
(41) based on the reduction of bis(neocuproine)
copper(II) as the chromogenic oxidizing agent by
antioxidants. A standard curve was prepared using
different concentrations of Trolox (TR). The results
were expressed as mmol TR per gram weight.
The statistical analyses were performed using
SPSS 11.5. Statistical comparisons among several
groups were made by one-way ANOVA. In any case,
a difference was considered as statistically significant
at P < 0.05.
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Results
The anticlastogenic effects of pretreatment with S.
officinalis extract on the frequency of MNPCEs and
the PCE/NCE ratio are shown in the Figure. There
was a significantly greater frequency of MNPCEs in
CYP-treated rats (group 5) compared with the control
(group 1) and the groups given only extract (groups
2, 3, 4). Pretreatment with 100 and 150 mg/kg bw
resulted in a MNPCE frequency of 27.62 and 20.38 in
2000 PCEs, respectively, which was significantly (P <
60
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Figure. Effect of Salvia officinalis extract on the frequencies of
MNPCEs and the PCE/NCE ratio on cyclophosphamidetreated rats. Values are expressed as mean ± SE; n = 6 for
each treatment group. Values with different letters are
significantly different (P < 0.05).

0.05) less than the rate of 52.25 observed with CYP
treatment. The number of MNPCEs was significantly
different between the groups treated with CYP
(groups 5, 6, 7, 8) and the control (group 1) (P <
0.05). Furthermore, the ratio of PCEs to NCEs, as
one index of cytotoxicity, was decreased in animals
treated with CYP. However, in animals pretreated
with S. officinalis extract, the PCE/NCE ratio was
increased significantly (P < 0.05) compared to the
CYP group (group 5).
The effects of S. officinalis and CYP on the levels
of lipid peroxidation in rat liver, kidney, and heart
tissues are shown in the Table. CYP treatment
led to a significant increase in MDA levels in all
groups as compared to the control group. Despite
this, significant restoration in the MDA profile
was observed in animals that received S. officinalis
pretreatment (100 and 150 mg/kg bw) as compared
to animals that received only CYP.
As shown in the Table, the activity of SOD in
liver, kidney, and heart tissue homogenates was
significantly decreased in CYP-treated rats when
compared with the control. Oral administration of
methanolic extract at dosages of 100 and 150 mg/kg
bw showed a significant increase in SOD activity in
all tissues of CYP-treated rats as compared to animals
that received only CYP.

Table. Effect of pretreatment of Salvia officinalis extract on the levels of lipid peroxidation expressed as MDA (μM/g protein), CAT (k/g
protein), and SOD (U/g protein) activities in rat liver, kidney, and heart tissues (n = 6 per group). Values are expressed as mean
± standard error. In each row, values with different superscripts indicate a significant difference (P < 0.05).
Group 1

Group 2

Group 3

Group 4

Group 5

Group 6

Group 7

Group 8

MDA

19.08 ± 0.87c

18.04 ± 0.67c

17.56 ± 0.79c

16.28 ± 0.61c

35.06 ± 1.33a

33.45 ± 0.73a

28.22 ± 0.81b

25.97 ± 1.44b

CAT

93.89 ± 3.15b

95.90 ± 2.81b

97.81 ± 1.39b

106.40 ± 2.05a

24.10 ± 0.87f

40.57 ± 1.73e

50.76 ± 1.58d

67.00 ± 1.84c

SOD

126.17 ± 1.86bc

130.16 ± 2.45b

137.80 ± 3.63ab

146.75 ± 3.54a

85.52 ± 1.67e

91.29 ± 1.96de

101.36 ± 1.81d

112.62 ± 2.42d

MDA

18.15 ± 1.14c

18.29 ± 0.96c

17.34 ± 0.95c

12.45 ± 0.63d

28.79 ± 1.31a

27.13 ± 0.70a

23.77 ± 0.56b

21.49 ± 1.21b

Kidney CAT

74.93 ± 1.61b

75.33 ± 1.48b

76.56 ± 1.79b

84.17 ± 1.88a

18.71 ± 0.60f

42.43 ± 1.49e

48.23 ± 1.28d

54.93 ± 1.80c

SOD

148.17 ± 2.75b

154.21 ± 1.79b

162.38 ± 3.24a

166.38 ± 3.05a

95.30 ± 1.79e

100.70 ± 1.93e

113.95 ± 4.75d

125.49 ± 2.07c

MDA

17.97 ± 0.82d

17.57 ± 0.87d

16.76 ± 0.73d

15.82 ± 0.83d

30.77 ± 0.91a

30.23 ± 0.76ab

28.16 ± 0.88b

22.83 ± 0.84c

CAT

54.64 ± 1.36b

56.80 ± 1.52b

57.09 ± 1.43b

63.42 ± 1.49a

14.73 ± 0.93e

16.55 ± 1.29e

25.53 ± 1.53d

36.75 ± 1.02c

SOD

96.94 ± 1.64b

97.81 ± 1.74b

99.45 ± 2.13ab

105.01 ± 2.71a

59.88 ± 2.15e

60.03 ± 2.22e

66.07 ± 1.62d

78.90 ± 1.30c

Liver

Heart
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In CYP-treated groups, CAT levels were
significantly decreased in all tissues as compared
to the control animals. In the pretreatment groups
receiving the methanolic extract of S. officinalis prior
to CYP, CAT activity was significantly increased in
liver and kidney tissues in a dose-dependent manner.
In heart tissue, only doses of 100 and 150 mg/kg bw
restored CAT activity as compared to animals that
received only CYP.
Cupric ion reducing capacity of the methanolic S.
officinalis extract was investigated for the first time in
this study. The TEAC value of the methanolic extract
of S. officinalis was 0.56 ± 0.03 mmol TR/g weight.
Discussion
CYP is an effective anticancer drug that belongs to
the class of nitrogen mustards. Its usage is severely
limited by its physiological side effects, and its
possible induction of genotoxicity in nontumor
cells has been documented in humans as well as in
a variety of animal species (42,43). The cytotoxic
effect of CYP is directly connected with free radicalmediated metabolism. It is rapidly metabolized
in the liver by cytochrome P-450 enzymes and
generates active alkylating metabolites such as
4-hydroxycyclophosphamide,
aldophosphamide,
and acrolein, which interfere with cellular DNA
synthesis in dividing cells and induce DNA singlestrand breaks (44) that may result in micronucleus
formation and cell death (45,46). Acrolein also
produces oxidative stress resulting in a decrease
in the activities of antioxidant enzymes and in an
increase in lipid peroxidation and the production of
intracellular ROS such as superoxide anion radicals,
hydroxyl radicals, and singlet oxygen. These reactive
oxygen and nitrogen species damage cellular lipid,
proteins, and DNA (47). It was reported that acrolein
and lipid peroxidation product MDA belongs to the
carbonyl compounds, which are very reactive and
can interact with amino acids of protein, causing
structural and functional changes in the enzymes
(46,48). In our study, we observed that intraperitoneal
administration of CYP led to oxidative stress as
evident from significant increases in MDA level
and decreases in antioxidant enzymes such as SOD
and CAT. Despite this, in animals pretreated with S.
officinalis extract, the extent of oxidative stress was
650

significantly decreased, especially with the 2 highest
doses of the extract.
The micronucleus test is one of the simplest shortterm assays for biomonitoring of the genotoxicity
of chemical carcinogens and the effect of putative
chemopreventive agents (12). The micronucleus
in young erythrocytes arises primarily from
chromosomal fragments or lagging chromosomes
that are not incorporated into the daughter nucleus
at the time of cell division in the erythropoietic
blast cells, and changes in the incidence of MNPCEs
are considered to reflect chromosomal damage
(49,50). Evaluation of erythropoietic cytotoxicity is
a convenient method of monitoring erythropoiesis.
The occurrence of fewer PCEs relative to NCEs is
considered to be an indicator of mutagen-induced
cytotoxicity (51).
In our study, administration of S. officinalis extract
for 7 days resulted in suppression of the mitotic
activity of the erythropoietic system and inhibition
of the micronucleus formation induced by CYP in rat
bone marrow cells. S. officinalis extract significantly
reduced the frequency of MNPCEs, increased
the PCE/NCE ratio, and showed a protective and
anticlastogenic effect against the side effects of CYP
wherein the protection was more pronounced at a
dose of 150 mg/kg bw.
A relationship between genotoxicity and
oxidative stress has been well demonstrated in
many experimental animal models (12,52,53). Many
authors found that genotoxicity and chromosomal
instability induced by many agents are directly
correlated with the parameters of oxidative stress
(54,55). Numerous studies have demonstrated that
ROS such as superoxide, hydroxyl radical anion,
and hydrogen peroxide are important mediators of
DNA damage and tissue injury (56). SOD and CAT
are the important antioxidant enzymes of cell defense
against free radical damage. SOD constitutes an
important link in the biological defense mechanism
through dismutation of endogenous cytotoxic
superoxide radicals to H2O2 and molecular oxygen,
which are deleterious to polyunsaturated fatty acids
and proteins (57). CAT is a hemoprotein, which
catalyzes the reduction of hydrogen peroxides
and is known to be involved in the detoxification
of H2O2 concentrations (58). In the present study,
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the activities of SOD and CAT decreased in CYPtreated rats as reported earlier (57,59), which could
be due to inactivation of cellular antioxidants by
the lipid peroxides and ROS that are produced due
to CYP intoxication. However, pretreatment with
the S. officinalis extract restored the enzyme levels
and decreased the formation of lipid peroxidation
byproduct MDA. The restoration of oxidative stress
by improving the antioxidant defense system might
be ascribed to the free radical scavenging/antioxidant
properties of the phytochemical constituents present
in S. officinalis.
There is increasing evidence that a plethora of
plant components such as vitamins, flavonoids,
terpenoids, polyphenolics, carotenoids, catechins,
and plant steroids can act as inhibitors of mutagenesis
(13,22). It is known that chemoprotective agents are
capable of exerting their antigenotoxic effects by a
single mechanism or a combination of mechanisms.
These mechanisms include the scavenging of ROS,
the inhibiting of formation of reactive carcinogenic
metabolites, the inducing of carcinogen-detoxifying
enzymes, and the influencing of apoptosis and
inhibiting of cell proliferation (52,60).
Several reports indicated that the compounds
responsible for antioxidative activity of S. officinalis
are mainly phenolic acids and flavonoids, namely
rosmarinic acid, caffeic acid, carnosol, and carnosic
acid (11,61). Through their free radical scavenging
capacity, S. officinalis and its phenolic compounds
have been shown to have protective effects against
oxidative stress (30). Therefore, the antioxidant
capacity of the plant extract was determined by the
CUPRAC method, which is capable of assaying
both hydrophilic and lipophilic antioxidants. The
CUPRAC method, using a cupric-neocuproine
(2,9-dimethyl-1,10-phenanthroline)
chelate
as
the chromogenic oxidant, is based on the redox
reaction with antioxidants producing the cuprousneocuproine chelate showing maximum light
absorption at 450 nm (41). The TEAC value of
methanolic extract was found to be 0.56 ± 0.03 mmol
TR/g weight. Since there are no data on the TEAC
values of S. officinalis methanolic extract before

measurement by the CUPRAC method, the result
was only compared to the data on the TEAC value of
S. officinalis measured by modified CUPRAC assays
in acetone aqueous solution (n = 3). The TEAC value
of the herbal tea extract of S. officinalis in acetone
aqueous solution was reported as 0.356 ± 0.005
mmol TR/g weight (32). The TEAC value of the
hydroalcoholic concentrated extracts of S. officinalis
measured by ABTS method was reported in the range
of 351.87–479.04 μmol TR/mL extract (62). Since
TEAC is a quantification of the effective antioxidant
activity of the extract, a higher TEAC value would
involve greater antioxidant activity. Our finding was
higher than the reported results that the methanolic
extraction of S. officinalis has a higher antioxidative
activity, which could be correlated to the total content
of polyphenols.
The pharmacological properties of S. officinalis
extract, which are mostly described as antioxidants,
might explain the way in which it protects the
tissues and bone marrow chromosomes against
CYP-induced genotoxicity and oxidative stress.
It was reported that essential oil of S. officinalis L.
and S. officinalis (sage) in the form of tea infusion
did not show any mutagenic effect and showed
antimutagenic effect against UV-induced mutations
in Escherichia coli and Saccharomyces cerevisiae in
the Salmonella/microsome mutagenicity assay Ames
test (22) and in the wing spot test of Drosophila
melanogaster, respectively (63). The latter authors
concluded that antioxidant activity and suppression
of metabolic activation could be mechanisms
through which sage or some of its components act
as desmutagens (63). In our study, the inhibition of
micronucleus formation by the extract suggests that
the antimutagenic potential of the extract is mostly
probably due to antioxidant and anticarcinogenic
activity related to the high antioxidant capacity of
the extract. The results of the in vitro antioxidant
studies carried out, as evidenced by measuring the
antioxidant capacity of the extract, also revealed that
S. officinalis extract may contain powerful inhibitor
compounds that might act as primary antioxidants
and react with free radicals.
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